Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests simple strategies to combat loneliness and suicidal feelings

NCT ID NCT06656975

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two treatments—Social Prescribing (connecting people with community activities) and Brief Cognitive Therapy (changing unhelpful thought patterns)—to see if they are practical and well-liked by adults who feel lonely or have suicidal thoughts. About 60 participants will try these approaches alongside their usual care. The goal is to see if these methods can help ease loneliness and improve well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Dec 2024

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Screen positive for either or both of the following during routine clinic screening: * Social isolation in the past 6 months, according to the screening question "How often do you feel isolated from others?" * Suicidal ideation in the past 12 months, according to the 9th item of the Patient Health Questionnaire (HQ-9) (per protocol) * Loneliness, according to the 3-item version of the University of California, Los Angeles (UCLA) Loneliness Scale (per protocol) * Are currently receiving or are able to initiate Collaborative Care Management at to participant's study site Exclusion Criteria: * Currently receiving or have an active referral for specialty mental health or substance use disorder treatment outside of primary care * Neurocognitively impaired according to chart diagnosis, self-report on the Eligibility Screening Survey, or inability to answer comprehension check questions during the Informed Consent process (per protocol) * Unable to participate in the interventions and research assessments due to planned travel or limited phone access (e.g., does not own phone) * Terminally ill or receiving of palliative care with less than 6 months life expectancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Social isolation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Social Isolation Suicidal Ideation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Michigan (Michigan Medicine)-Brighton Health Center

    Brighton, Michigan, 48116, United States

  • University of Michigan (Michigan Medicine)-Canton Center

    Canton, Michigan, 48187, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.